Financial Performance - The company's operating revenue for the first half of 2023 reached ¥132,311,038.48, a significant increase of 2,387.13% compared to ¥5,319,818.50 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was ¥9,260,651.37, recovering from a loss of ¥33,837,552.91 in the previous year[18]. - The net cash flow from operating activities was ¥12,918,052.10, a substantial improvement from a negative cash flow of ¥157,278,353.22 in the same period last year[18]. - Basic earnings per share for the first half of 2023 were ¥0.01, compared to a loss of ¥0.05 in the same period last year[19]. - The weighted average return on net assets increased by 1.96 percentage points to 0.48% from -1.48% in the previous year[19]. - The company reported a net profit of ¥16,889,497.84 after deducting non-recurring gains and losses, compared to a loss of ¥21,147,318.29 in the same period last year[18]. - The net profit for the first half of 2023 was ¥13,538,496.19, a turnaround from a net loss of ¥34,490,155.97 in the same period of 2022[92]. - The company reported a comprehensive income total of -¥40,191,292.52 for the first half of 2023, improving from -¥115,191,024.44 in the same period of 2022[93]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,367,963,787.78, showing a slight increase of 0.27% from ¥3,358,946,479.41 at the end of the previous year[18]. - The net assets attributable to shareholders decreased by 3.30% to ¥1,908,690,551.67 from ¥1,973,908,147.74 at the end of the previous year[18]. - The company's total assets as of June 30, 2023, amounted to ¥2,644,951,670.55, slightly up from ¥2,642,779,294.54 at the end of 2022[89]. - Total liabilities increased to ¥735,790,178.96 from ¥654,725,280.43 year-over-year, reflecting a rise of approximately 12.4%[89]. - The company's total liabilities at the end of the reporting period were CNY 1,908,690,551.67, reflecting a decrease from CNY 2,200,598,853.33[114]. Investment and Projects - The company is developing the Tianchen Energy integrated solar and storage project, with a focus on high-efficiency solar cells and energy storage systems, amid a 98.3% year-on-year increase in new renewable energy installations[24]. - The Tianchen Health City project is ongoing, with the East Block 1A project completed in 2022 and sales continuing, while the East Block 1B project has a total investment of CNY 1.71 billion and a construction period of 2.5 years[27]. - The company signed a project investment contract with the Wuhu Municipal Government to build a new energy industry base, planning to establish a 20GW solar cell and 20GW energy storage inverter manufacturing project[32]. - The company is actively pursuing government approvals for its newly renovated rehabilitation hospital, which has completed its construction phase[28]. Market and Competition - The company faces macroeconomic risks due to increasing uncertainties in the international political and economic environment, which may impact its current and future business operations[50]. - The traditional taxi business continues to be challenged by the rise of ride-hailing services, intensifying competition that may adversely affect operational performance[50]. - The company is closely monitoring the impact of national real estate policies on its Tianchen Health City project, which could affect financing and sales[50]. - The company is actively responding to market competition risks, particularly in the context of its transition to new business areas[50]. Corporate Governance and Management - Recent changes in the board of directors and management include the election of a new chairman and several directors, which may influence future strategic directions[54][55]. - The company has not proposed any profit distribution or capital reserve increase for the first half of 2023, indicating a focus on reinvestment or stabilization[57]. - The company has not disclosed any significant developments regarding employee stock ownership plans or other incentive measures, suggesting a potential area for future focus[58]. - The company has not reported any environmental compliance issues or significant initiatives related to carbon emission reduction during the reporting period[60]. Financial Instruments and Accounting Policies - The financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring compliance and accuracy in financial reporting[125]. - The company recognizes revenue when the customer obtains control of the goods or services, which means they can use and derive almost all economic benefits from them[193]. - The company recognizes financial liabilities when the current obligations are fully or partially discharged, or when existing liabilities are replaced with new financial liabilities under substantially different terms[147]. - The company estimates expected credit losses for financial assets based on past events, current conditions, and forecasts of future economic conditions, using a probability-weighted amount of the difference between cash flows expected to be received and contractual cash flows[149]. Cash Flow and Financing Activities - The cash flow from operating activities showed a positive net amount of ¥12,918,052.10 in the first half of 2023, a turnaround from -¥157,278,353.22 in the same period of 2022[99]. - The cash flow from financing activities generated a net amount of ¥106,079,934.88 in the first half of 2023, compared to ¥159,915,973.95 in the same period of 2022, indicating a decrease of about 33.6%[99]. - The company reported cash inflows from investment activities totaling ¥97,433,963.61, compared to ¥24,599,599.81 in the first half of 2022, marking an increase of approximately 295.5%[99]. Shareholder Information - The total number of common shareholders as of the end of the reporting period is 14,996[74]. - The largest shareholder, Shanghai Zhongsheng Hongqiao Enterprise Management Co., Ltd., holds 172,225,164 shares, accounting for 25.08% of the total shares[76]. - Guohua Life Insurance Co., Ltd. - Universal No. 3 holds 104,088,332 shares, representing 15.16% of the total shares[76]. - The top ten shareholders include several entities with no shares under lock-up conditions, indicating a high level of liquidity[78].

证券代码：600620 股票简称：天宸股份 编号：临2023-042 上海市天宸股份有限公司 第十一届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 上海市天宸股份有限公司（以下简称"公司"）第十一届董事会第 二次会议于 2023 年 8 月 28 日以通讯方式召开。本次会议应参与表决 董事 9 人，实际参与表决董事 9 人。会议的召集、召开等程序符合 《公司法》和《公司章程》等的相关规定。 二、董事会会议审议情况 公司全体董事审议并通过了如下议案： 1、关于《公司 2023 年半年度报告全文及摘要》的议案 此项议案表决情况为：9 票同意，0 票反对，0 票弃权。 相关内容详见上海证券交易所网站 www.sse.com.cn。 现根据上海市政府发布的《关于进一步规范本市工程建设项目工 程款结算和支付工作的通知》的相关要求，建设单位应当以项目为单 位向施工单位提供担保金额不低于签约合同价 10%的工程款支付担保。 鉴于此，天宸健康拟作为保函申请人，用其自有资金 1,500 ...

证券代码：600620 股票简称：天宸股份 编号：临2023-043 上海市天宸股份有限公司 关于控股子公司向银行申请开具履约保函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 上海市天宸股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日以通讯方式召开第十一届董事会第二次会议，审议通过了《关 于控股子公司向银行申请开具履约保函的议案》（公告编号：临 2023-042），现将有关事项公告如下： 一、开具履约保函的概述 为建设开发天宸健康城之东地块 1B 项目，公司控股子公司上海 天宸健康管理有限公司（以下简称"天宸健康"）与浙江国丰集团有 限公司（以下简称"浙江国丰"）签署了《上海市天宸健康城项目东 地块 1-B 期总承包工程合同》。 鉴于此，天宸健康拟作为保函申请人，用其自有资金 1,500 万元， 以全额保证金的形式向上海浦东发展银行股份有限公司虹口支行（以 下简称"浦发银行虹口支行"）提出申请，由浦发银行虹口支行开立 履约保函，受益人为浙江国丰。 天宸健康将根据年度工程款支付金额 10%分期提 ...

关于赎回私募投资基金份额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：600620 股票简称：天宸股份 编号: 临2023-041 上海市天宸股份有限公司 上海市天宸股份有限公司（以下简称"公司"）于 2020 年 7 月 30 日出资人民币 5,000 万元认购百济价值成长私募证券投资基金（以下 简称"百济基金"），百济基金已在中国证券投资基金业协会备案（公 告编号：临 2020-026、临 2020-031）。2022 年 12 月 1 日公司发起赎 回百济基金份额 30,350,000 的申请，赎回资金人民币 30,164,865 元 已于 2022 年 12 月 5 日到账（公告编号：临 2022-032）。赎回后，公 司持有百济基金份额为 19,514,678.85。 日前，百济基金已到期并完成清算，公司已赎回持有的百济基金 份额 19,514,678.85，赎回资金人民币 20,926,566.01 元(赎回日单 位净值：1.0724 元)。两次赎回累积收益人民币 1,091,431.01 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利 0.03 元（含税） 证券代码：600620 证券简称：天宸股份 公告编号：2023-040 上海市天宸股份有限公司 2022 年年度权益分派实施公告 1. 发放年度：2022 年年度 2. 分派对象： 三、 相关日期 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2023/8/15 | － | 2023/8/16 | 2023/8/16 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司 2023 年 6 月 26 日的 2022 年年度股东大会审议通过，相关股东 大会决议公告于 2023 年 6 月 27 日在《中国证券报》、《上海证券报》和上海证券交易所网站 www.sse.com.cn 上刊载。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：600620 证券简称：天宸股份 公告编号：临 2023-030 上海市天宸股份有限公司 关于召开 2022 年度业绩说明会的公告 投资者可于 2023 年 06 月 21 日(星期三) 至 06 月 29 日(星期 四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通 过公司邮箱 tc@shstc.com 进行提问。公司将在说明会上对投资者普 遍关注的问题进行回答。 上海市天宸股份有限公司（以下简称"公司"）已于 2023 年 4 月 8 日发布公司 2022 年度报告，为便于广大投资者更全面深入地了解 公司 2022 年度经营成果、财务状况，公司计划于 2023 年 06 月 30 日 上午 10:00-11:00 举行 2022 年度业绩说明会，就投资者关心的问题 进行交流。 一、 说明会类型 会议召开时间：2023 年 06 月 30 日(星期五)上午 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址： ht ...

2023 年第一季度报告 证券代码：600620 证券简称：天宸股份 上海市天宸股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人叶茂菁、主管会计工作负责人杨炯祺及会计机构负责人（会计主管人员）庄艳欣保证 季度报告中财务信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同期增减 | | --- | --- | --- | | | | 变动幅度(%) | | 营业收入 | 66,017,794.89 | 1,594.99 | | 归属于上市公司股东的净利润 | 7,482,381.17 | 不适用 | | 归属于上市公司股东的扣除非经常 | 15,905,470.75 | 不适用 | | 性 ...

Financial Performance - In 2022, Tianchen Co., Ltd. reported a total revenue of ¥243,734,574.84, representing a significant increase of 482.85% compared to ¥41,817,567.02 in 2021[19] - The net profit attributable to shareholders of the listed company for 2022 was ¥35,935,674.36, a decrease of 70.80% from ¥123,065,844.74 in 2021[19] - The net profit after deducting non-recurring gains and losses was ¥90,996,573.03, which is an increase of 11.22% compared to ¥81,813,140.02 in 2021[19] - Basic earnings per share for 2022 were ¥0.05, down 72.22% from ¥0.18 in 2021[20] - The weighted average return on net assets decreased by 3.84 percentage points to 1.54% in 2022 from 5.38% in 2021[20] - The company reported a net profit attributable to shareholders of ¥3,593.57 million, a decrease of 70.80% from ¥12,306.58 million in the previous year[61] - The net profit attributable to shareholders was 35.94 million RMB, a decrease of 70.80% from 123.07 million RMB in the previous year, primarily due to a decline in the fair value of financial assets[29] - The company reported a net profit of CNY 80.47 million for the Health Management subsidiary, a turnaround from a net loss of CNY 8.17 million in the previous year, attributed to significant sales from the Health City 1A project[71] Cash Flow and Assets - The net cash flow from operating activities was -¥145,732,775.99, showing an improvement from -¥211,410,099.71 in 2021[19] - The company’s cash flow from operating activities showed a significant negative figure of -138.63 million RMB in the first quarter, but improved to 121.61 million RMB in the fourth quarter[23] - The company’s cash flow from operating activities was positively impacted by the sales from the Health City 1A project, contributing to the increase in cash and cash equivalents[64] - Cash and cash equivalents rose to CNY 478,291,969.53 in 2022, up from CNY 193,415,072.33 in 2021, an increase of 147%[180] - The total assets of the company reached ¥3,358,946,479.41, an increase of 22.98% from ¥2,731,229,896.46 at the end of 2021[19] - The company’s total assets decreased from ¥2,920,666,774.76 in 2021 to ¥2,642,779,294.54 in 2022, a decline of about 9.5%[186] - Total current liabilities surged to CNY 612,013,331.54 in 2022 from CNY 68,046,926.86 in 2021, reflecting a growth of 800%[181] Project Developments - The Tianchen Health City 1A project generated a net profit of 80.47 million RMB, an increase of 886.39% compared to a net loss of 8.17 million RMB in the previous year[30] - The company completed the Tianchen Health City 1A project and began sales in December 2022, contributing significantly to revenue growth[30] - The company plans to invest in the Tianchen Health City East Block 1B project, which will include office, hotel, and business complex buildings[30] - The company plans to invest approximately 1.71 billion yuan in the Tianchen Health City 1B project, which is expected to take 2.5 years to complete[36] - The company has initiated the construction of the Tianchen Health City 1B project, focusing on quality, progress, and cost control[78] Risks and Challenges - The company has indicated potential risks in its future plans and strategies, urging investors to remain cautious[6] - The taxi business is expected to face ongoing challenges with limited revenue and profit contributions due to market conditions and competition from ride-hailing services[37] - The company experienced a decrease in taxi operation and property leasing income due to market conditions and related policies[29] - The company is actively seeking new tenants for its properties but faces uncertainty in the leasing market due to economic conditions[37] - The company faces risks including macroeconomic uncertainties, policy changes affecting real estate, and competition from ride-hailing services[80] Corporate Governance - The company emphasizes the importance of respecting and maintaining the legitimate rights and interests of shareholders, particularly small and medium-sized investors[85] - The company adheres to strict information disclosure practices, ensuring transparency in accordance with relevant laws and regulations[85] - The company has implemented measures to ensure the independence of its operations from its controlling shareholders[86] - The company has established a strategic development department to explore new business avenues and enhance its core competitiveness[79] - The company is committed to improving corporate governance and internal controls to adapt to the evolving business landscape[79] Shareholder Information - The company has a total of 16,032 common stock shareholders as of the end of the reporting period, an increase from 15,158 at the end of the previous month[153] - The largest shareholder, Shanghai Zhongsheng Hongqiao Enterprise Management Co., Ltd., holds 25.08% of the shares, totaling 172,225,164 shares[156] - Guohua Life Insurance Co., Ltd. holds 15.16% of the shares, totaling 104,088,332 shares[156] - The total number of shares held by the top ten shareholders includes 172,225,164 shares from Shanghai Zhongsheng and 104,088,332 shares from Guohua Life Insurance, indicating significant concentration of ownership[156] Audit and Compliance - The financial statements for the year ended December 31, 2022, were audited and found to fairly present the financial position and results of operations[169] - The audit report emphasizes the importance of evaluating the appropriateness of accounting policies and estimates made by management[175] - The audit procedures included evaluating the design and operating effectiveness of internal controls related to revenue recognition[172] - The internal control audit report for the financial year 2022 received a standard unqualified opinion, confirming the effectiveness of the internal control system[120] - The company has established a comprehensive internal control system that meets the requirements of regulatory authorities, ensuring effective risk management and compliance[119]

2022 年第三季度报告 单位：元 币种：人民币 证券代码：600620 证券简称：天宸股份 上海市天宸股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 | --- | --- | --- | --- | --- | |------------------------------------------------|---------------|--------------------------------------|----------------|-------------------------------------- ...

天宸股份 2022 年半年度报告 公司代码：600620 公司简称：天宸股份 上海市天宸股份有限公司 2022 年半年度报告 1 / 121 天宸股份 2022 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人叶茂菁、主管会计工作负责人杨炯祺及会计机构负责人（会计主管人员）张春华 声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的公司未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质性承 诺，敬请投资者注意投资风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况？ 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司经营风险已在 ...